A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner

Osvaldo Martinez, Esther Ndungo, Lee Tantral, Emily Happy Miller, Lawrence W. Leung, Kartik Chandran, Christopher F. Basler

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Zaire Ebola virus (EBOV) is a zoonotic pathogen that causes severe hemorrhagic fever in humans. A single viral glycoprotein (GP) mediates viral attachment and entry. Here, virus-like particle (VLP)-based entry assays demonstrate that a GP mutant, GPF88A, which is defective for entry into a variety of human cell types, including antigen-presenting cells (APCs), such as macrophages and dendritic cells, can mediate viral entry into mouse CD11bα APCs. Like that of wild-type GP (GP-wt), GP-F88A-mediated entry occurs via a macropinocytosis-related pathway and requires endosomal cysteine proteases and an intact fusion peptide. Several additional hydrophobic residues lie in close proximity to GP-F88, including L111, I113, L122, and F225. GP mutants in which these residues are mutated to alanine displayed preferential and often impaired entry into several cell types, although not in a species-specific manner. Niemann-Pick C1 (NPC1) protein is an essential filovirus receptor that binds directly to GP. Overexpression of NPC1 was recently demonstrated to rescue GP-F88A-mediated entry. A quantitative enzyme-linked immunosorbent assay (ELISA) demonstrated that while the F88A mutation impairs GP binding to human NPC1 by 10-fold, it has little impact on GP binding to mouse NPC1. Interestingly, not all mouse macrophage cell lines permit GP-F88A entry. The IC-21 cell line was permissive, whereas RAW 264.7 cells were not. Quantitative reverse transcription (RT)-PCR assays demonstrate higher NPC1 levels in GP-F88A permissive IC-21 cells and mouse peritoneal macrophages than in RAW 264.7 cells. Cumulatively, these studies suggest an important role for NPC1 in the differential entry of GP-F88A into mouse versus human APCs.

Original languageEnglish (US)
Pages (from-to)3324-3334
Number of pages11
JournalJournal of Virology
Volume87
Issue number6
DOIs
StatePublished - Mar 2013

Fingerprint

Ebolavirus
glycoproteins
Glycoproteins
mutation
Mutation
cells
antigen-presenting cells
Antigen-Presenting Cells
mice
macrophages
Ebola virus envelope glycoprotein
Zaire Ebola virus
CD11b Antigens
Filoviridae
Macrophages
cell lines
Cell Line
mutants
virus-like particles
Cysteine Proteases

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. / Martinez, Osvaldo; Ndungo, Esther; Tantral, Lee; Miller, Emily Happy; Leung, Lawrence W.; Chandran, Kartik; Basler, Christopher F.

In: Journal of Virology, Vol. 87, No. 6, 03.2013, p. 3324-3334.

Research output: Contribution to journalArticle

Martinez, Osvaldo ; Ndungo, Esther ; Tantral, Lee ; Miller, Emily Happy ; Leung, Lawrence W. ; Chandran, Kartik ; Basler, Christopher F. / A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. In: Journal of Virology. 2013 ; Vol. 87, No. 6. pp. 3324-3334.
@article{1bc7f1030a4040d7af728a5bcb09c63d,
title = "A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner",
abstract = "Zaire Ebola virus (EBOV) is a zoonotic pathogen that causes severe hemorrhagic fever in humans. A single viral glycoprotein (GP) mediates viral attachment and entry. Here, virus-like particle (VLP)-based entry assays demonstrate that a GP mutant, GPF88A, which is defective for entry into a variety of human cell types, including antigen-presenting cells (APCs), such as macrophages and dendritic cells, can mediate viral entry into mouse CD11bα APCs. Like that of wild-type GP (GP-wt), GP-F88A-mediated entry occurs via a macropinocytosis-related pathway and requires endosomal cysteine proteases and an intact fusion peptide. Several additional hydrophobic residues lie in close proximity to GP-F88, including L111, I113, L122, and F225. GP mutants in which these residues are mutated to alanine displayed preferential and often impaired entry into several cell types, although not in a species-specific manner. Niemann-Pick C1 (NPC1) protein is an essential filovirus receptor that binds directly to GP. Overexpression of NPC1 was recently demonstrated to rescue GP-F88A-mediated entry. A quantitative enzyme-linked immunosorbent assay (ELISA) demonstrated that while the F88A mutation impairs GP binding to human NPC1 by 10-fold, it has little impact on GP binding to mouse NPC1. Interestingly, not all mouse macrophage cell lines permit GP-F88A entry. The IC-21 cell line was permissive, whereas RAW 264.7 cells were not. Quantitative reverse transcription (RT)-PCR assays demonstrate higher NPC1 levels in GP-F88A permissive IC-21 cells and mouse peritoneal macrophages than in RAW 264.7 cells. Cumulatively, these studies suggest an important role for NPC1 in the differential entry of GP-F88A into mouse versus human APCs.",
author = "Osvaldo Martinez and Esther Ndungo and Lee Tantral and Miller, {Emily Happy} and Leung, {Lawrence W.} and Kartik Chandran and Basler, {Christopher F.}",
year = "2013",
month = "3",
doi = "10.1128/JVI.01598-12",
language = "English (US)",
volume = "87",
pages = "3324--3334",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner

AU - Martinez, Osvaldo

AU - Ndungo, Esther

AU - Tantral, Lee

AU - Miller, Emily Happy

AU - Leung, Lawrence W.

AU - Chandran, Kartik

AU - Basler, Christopher F.

PY - 2013/3

Y1 - 2013/3

N2 - Zaire Ebola virus (EBOV) is a zoonotic pathogen that causes severe hemorrhagic fever in humans. A single viral glycoprotein (GP) mediates viral attachment and entry. Here, virus-like particle (VLP)-based entry assays demonstrate that a GP mutant, GPF88A, which is defective for entry into a variety of human cell types, including antigen-presenting cells (APCs), such as macrophages and dendritic cells, can mediate viral entry into mouse CD11bα APCs. Like that of wild-type GP (GP-wt), GP-F88A-mediated entry occurs via a macropinocytosis-related pathway and requires endosomal cysteine proteases and an intact fusion peptide. Several additional hydrophobic residues lie in close proximity to GP-F88, including L111, I113, L122, and F225. GP mutants in which these residues are mutated to alanine displayed preferential and often impaired entry into several cell types, although not in a species-specific manner. Niemann-Pick C1 (NPC1) protein is an essential filovirus receptor that binds directly to GP. Overexpression of NPC1 was recently demonstrated to rescue GP-F88A-mediated entry. A quantitative enzyme-linked immunosorbent assay (ELISA) demonstrated that while the F88A mutation impairs GP binding to human NPC1 by 10-fold, it has little impact on GP binding to mouse NPC1. Interestingly, not all mouse macrophage cell lines permit GP-F88A entry. The IC-21 cell line was permissive, whereas RAW 264.7 cells were not. Quantitative reverse transcription (RT)-PCR assays demonstrate higher NPC1 levels in GP-F88A permissive IC-21 cells and mouse peritoneal macrophages than in RAW 264.7 cells. Cumulatively, these studies suggest an important role for NPC1 in the differential entry of GP-F88A into mouse versus human APCs.

AB - Zaire Ebola virus (EBOV) is a zoonotic pathogen that causes severe hemorrhagic fever in humans. A single viral glycoprotein (GP) mediates viral attachment and entry. Here, virus-like particle (VLP)-based entry assays demonstrate that a GP mutant, GPF88A, which is defective for entry into a variety of human cell types, including antigen-presenting cells (APCs), such as macrophages and dendritic cells, can mediate viral entry into mouse CD11bα APCs. Like that of wild-type GP (GP-wt), GP-F88A-mediated entry occurs via a macropinocytosis-related pathway and requires endosomal cysteine proteases and an intact fusion peptide. Several additional hydrophobic residues lie in close proximity to GP-F88, including L111, I113, L122, and F225. GP mutants in which these residues are mutated to alanine displayed preferential and often impaired entry into several cell types, although not in a species-specific manner. Niemann-Pick C1 (NPC1) protein is an essential filovirus receptor that binds directly to GP. Overexpression of NPC1 was recently demonstrated to rescue GP-F88A-mediated entry. A quantitative enzyme-linked immunosorbent assay (ELISA) demonstrated that while the F88A mutation impairs GP binding to human NPC1 by 10-fold, it has little impact on GP binding to mouse NPC1. Interestingly, not all mouse macrophage cell lines permit GP-F88A entry. The IC-21 cell line was permissive, whereas RAW 264.7 cells were not. Quantitative reverse transcription (RT)-PCR assays demonstrate higher NPC1 levels in GP-F88A permissive IC-21 cells and mouse peritoneal macrophages than in RAW 264.7 cells. Cumulatively, these studies suggest an important role for NPC1 in the differential entry of GP-F88A into mouse versus human APCs.

UR - http://www.scopus.com/inward/record.url?scp=84874711539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874711539&partnerID=8YFLogxK

U2 - 10.1128/JVI.01598-12

DO - 10.1128/JVI.01598-12

M3 - Article

VL - 87

SP - 3324

EP - 3334

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 6

ER -